A detailed history of Franklin Resources Inc transactions in Erasca, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 65,872 shares of ERAS stock, worth $179,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,872
Holding current value
$179,830
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.17 - $3.28 $142,942 - $216,060
65,872 New
65,872 $179,000
Q3 2023

Nov 13, 2023

SELL
$1.97 - $2.91 $60,735 - $89,715
-30,830 Reduced 71.44%
12,324 $24,000
Q2 2023

Aug 11, 2023

BUY
$2.57 - $3.3 $110,905 - $142,408
43,154 New
43,154 $119,000

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $333M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.